Certainly government is playing a role.
One of the challenges in this field, which has changed dramatically since I entered it in the early 1990s, is that the large pharmaceutical industries have abandoned this field. The people who used to make drugs in this field—the Mercks and the Pfizers of the world—are not in this business, for all the reasons that you've heard before. The return on investment is too low.
That means we must, as a society, invest in this area if we're going to prevent the challenge that Dr. Outterson just noted, which is having every medical intervention be more dangerous than it needs to be.